S4 Medical

S4 Medical is a medical technology company focused on developing innovative solutions for atrial fibrillation (AFib) treatment. Their flagship product, esolution, is the first and only FDA-cleared device designed to deviate the esophagus and reduce the risk of thermal injury during AFib ablation procedures. This device utilizes vacuum suction and mechanical force to safely reposition the esophagus away from the ablation catheter, minimizing the potential for complications.

S4 Medical boasts a strong team of experienced professionals in the medical device industry, led by co-founders Bill Fuller and Dr. Emile Daoud. They have a robust medical advisory board comprised of leading experts in cardiac electrophysiology. The company's commitment to research and development is evident in their numerous publications and presentations highlighting the efficacy and safety of the esolution device.

S4 Medical is a medical device company focused on improving the safety and efficacy of atrial fibrillation ablation procedures. They have developed the esolution device, the first and only FDA-cleared device to deviate the esophagus and reduce the risk of ablation-related esophageal injury during treatment of atrial fibrillation. This innovative device works by providing bilateral deviation to accommodate each patient’s pulmonary vein anatomy and any lesion strategy, allowing electrophysiologists to perform ablation with confidence anywhere in the left atrium.

S4 Medical cultivates a culture of innovation and collaboration, driven by a shared passion for improving patient care. They emphasize teamwork, with a diverse team of experts from various fields, including medical professionals, engineers, and business leaders. This diverse background allows for a dynamic exchange of ideas and a focus on finding solutions to complex challenges. The company's commitment to advancing medical technology is evident in their dedication to research and development, fostering a culture of continuous learning and growth.